Who are the key players in US Medical Elastomer Market industry?

The top five players in the US Medical Elastomer Market include Dow Inc., DuPont, BASF SE, Eastman Chemical Company, and Momentive Performance Materials. These companies drive innovation by developing advanced elastomeric materials, expanding product portfolios, and investing in research to meet the growing demand for medical applications.

What is the US Medical Elastomer Market growth?

The US Medical Elastomer Market has experienced steady growth, driven by increasing demand for medical devices and equipment. In 2023, companies like Dow Inc. reported significant sales increases for silicone-based elastomers due to their widespread adoption in healthcare applications, supporting the market's robust upward trajectory.

Which segment accounted for the largest US Medical Elastomer Market share?

The medical tubing and catheters segment accounted for the largest market share in the US Medical Elastomer Market. Extensive use of elastomers for manufacturing flexible, durable, and biocompatible tubing and catheters in various medical procedures has propelled this segment's dominance in recent years.

What are the factors driving the US Medical Elastomer Market?

Growing demand for minimally invasive medical procedures and an increase in the elderly population are key drivers. For example, DuPont’s expansion of its medical-grade silicone elastomer production aims to meet stringent healthcare standards, supporting the market’s accelerated growth.

Which type accounted for the largest US Medical Elastomer Market share?

Silicone elastomers held the largest share in the US Medical Elastomer Market. Their superior properties, such as biocompatibility, flexibility, and resistance to chemicals, make them an ideal choice for various medical applications, including implants and surgical instruments.

Home Chemical & Material

US Medical Elastomer Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: US Medical Elastomer Market
Brand: Bussiness Insights

US Medical Elastomer Market: by Type (Thermoplastic Elastomers, Thermoset Elastomers), Application (Medical Tubes, Catheters, Syringes, Gloves, Implants, Seals & Gaskets), Distribution Channels (Direct Sales, Distributors/Wholesalers, Online, Retail Pharmacies), Technology (Injection Molding, Extrusion, Compression Molding, 3D Printing), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 23-07-2025 | Format: PDF | Report ID:1566

US Medical Elastomer Market Forecast 2025-2035

The US Medical Elastomer Market is poised for significant growth between 2025 and 2035, driven by increasing demand for advanced medical devices, regulatory support for innovative material use, and rapid technological advancements. Key market players are focusing on the development of elastomers with enhanced biocompatibility and durability to meet evolving industry needs. Market segments include various elastomer types, applications such as medical tubes and catheters, and distribution channels ranging from direct sales to online platforms. The market is expected to witness robust growth, especially in thermoplastic elastomers and high-performance applications.

Latest Market Dynamics

Key Drivers

Rising demand for minimally invasive medical devices: As healthcare providers increasingly adopt minimally invasive surgical techniques, the need for flexible, durable, and biocompatible elastomer components has surged. For example, Dow Inc.

Shift towards silicone-based medical elastomers: Silicone elastomers are gaining traction for their enhanced performance in implants, catheters, and tubing. Momentive Performance Materials Inc. introduced advanced silicone elastomers in June 2024 for critical care devices.
Increased adoption of 3D printing technology: The integration of 3D printing enables rapid prototyping and personalized healthcare solutions. BASF SE partnered with healthcare OEMs in July 2024 to offer 3D-printable elastomer materials.

Expansion into high-growth application areas: The rising use of elastomers in critical applications such as surgical gloves and drug delivery systems presents lucrative opportunities. For instance, Eastman Chemical Company invested in new elastomer production facilities targeting these segments in August 2024.
Growth in direct-to-hospital distribution channels: Hospitals are increasingly sourcing directly from manufacturers, providing new market access opportunities. Teknor Apex established direct sales partnerships with healthcare networks in September 2024.

Cost pressures from commodity fluctuations: Volatile raw material prices can impact profit margins for elastomer manufacturers. Celanese Corporation reported margin pressures and initiated cost optimization measures in July 2024.
Supply chain disruptions and logistics constraints: Ongoing global disruptions challenge timely delivery and inventory management. Kraton Corporation faced logistics delays and implemented a risk mitigation strategy in June 2024.

Intense competition from substitute materials: Alternative materials like advanced plastics can limit the growth of medical elastomers. PolyOne Corporation responded by enhancing technical differentiation in June 2024.
Stringent quality and compliance standards: Failing to meet regulatory quality benchmarks can restrict market access. Saint-Gobain Performance Plastics prioritized compliance testing after a regulatory review in July 2024.

The market share of US medical elastomers by type in 2025 highlights the dominance of thermoplastic elastomers, driven by their flexibility, processability, and rising usage in disposable medical devices. Thermoset elastomers continue to be widely used for their superior mechanical strength in applications requiring durability. Silicone elastomers contribute significantly due to biocompatibility, especially in implants and tubing segments. Ongoing product innovation and regulatory approvals are increasing adoption rates across healthcare supply chains.

In 2025, medical tubes represent the largest application segment for medical elastomers in the US, accounting for a significant market share owing to their widespread use in patient care and drug delivery systems. Catheters and syringes follow closely due to the growing number of surgical interventions and need for sterile, single-use medical products. The market for gloves and implants is also rising, with elastomers preferred for their durability and skin compatibility.

The US medical elastomer market revenue is projected to exhibit steady growth, rising from USD 2,550 million in 2020 to approximately USD 5,670 million by 2035. This upward trend is fueled by rising healthcare expenditure, technological advancements, and the expansion of medical manufacturing infrastructure. Key segments contributing to revenue growth include thermoplastic elastomers and their deployment in novel healthcare products, alongside expanding distribution across online and pharmacy channels.

Year-on-year growth in the US medical elastomer market has averaged between 5.5% and 7.0% over the past decade, with a peak in growth during the mid-2020s as post-pandemic healthcare and device production normalized. Gradual stabilization is anticipated through 2035 as the market matures, with new technology adoption and regulatory shifts continuing to influence yearly variations.

Regional analysis for 2025 reveals that the Northeast region leads due to its concentration of pharmaceutical and medical device manufacturing companies. The Midwest follows, benefiting from a robust distribution network and large hospital presence. The South and West regions together account for a substantial share, driven by healthcare infrastructure expansion and increasing demand for advanced medical materials in these areas.

The US medical elastomer industry is characterized by the strong presence of global conglomerates and innovative specialty chemical manufacturers. Dow Inc. leads the market with a diverse product portfolio and strong supply chain integration. DuPont de Nemours, BASF SE, and Eastman Chemical Company also command significant shares due to their advanced R&D and extensive hospital network reach. Mid-tier companies such as Teknor Apex are rapidly increasing their market footprint with specialized healthcare offerings.

In 2025, leading buyers of medical elastomers in the US include major hospital systems and healthcare OEMs. Hospital networks represent the largest segment, followed by medical device manufacturers and pharmaceutical companies, reflecting the essential role elastomers play in both product manufacturing and direct patient care environments. Growth in buyers is linked to increasing procurement of next-generation medical materials.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	USD 3,120 Million (2025)
Regions	Northeast US, Midwest US, South US, West US
Segments	By Type: Thermoplastic Elastomers, Thermoset Elastomers, Silicone Elastomers, Polyurethane Elastomers, Natural Rubber Elastomers, Others; By Application: Medical Tubes, Catheters, Syringes, Gloves, Implants, Seals & Gaskets; Technology, Distribution Channels, Organization Size
Players	Dow Inc., DuPont de Nemours, Inc., BASF SE, Eastman Chemical Company, Celanese Corporation, Kraton Corporation, Teknor Apex, RTP Company, PolyOne Corporation, Mitsubishi Chemical Group Corporation, ExxonMobil Chemical, Momentive Performance Materials Inc., Saint-Gobain Performance Plastics, Elkem Silicones, Avantor, Inc.

June 2024: Momentive Performance Materials launched its latest silicone elastomer series targeted for healthcare and implantable applications.
July 2024: BASF SE announced a partnership with a leading medical device OEM to co-develop 3D printable elastomeric materials for custom healthcare products.
August 2024: Eastman Chemical Company expanded its US elastomer manufacturing facility to cater to advanced tubing and glove applications.
September 2024: Teknor Apex formed direct sales collaborations with national hospital systems, optimizing medical elastomer distribution channels.
July 2024: Saint-Gobain Performance Plastics initiated a comprehensive regulatory testing program to assure compliance for new elastomer grades.

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

US Medical Elastomer Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

US Medical Elastomer Market Forecast 2025-2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

US Medical Elastomer Market Share by Type, 2025

US Medical Elastomer Market Share by Application, 2025

US Medical Elastomer Market Revenue (USD Million), 2020-2035

US Medical Elastomer Market YOY Growth (%), 2020-2035

US Medical Elastomer Market by US Regions, 2025

US Medical Elastomer Market Top Players Share, 2025

US Medical Elastomer Market Top Buyers Share, 2025

Study Coverage

Key Recent Developments

Frequently asked questions